A parallel-group, pharmacokinetic study to evaluate the efficacy of nevirapine and lopinavir/ritonavir in HIV-infected patients with drug-resistant tuberculosis

Trial Profile

A parallel-group, pharmacokinetic study to evaluate the efficacy of nevirapine and lopinavir/ritonavir in HIV-infected patients with drug-resistant tuberculosis

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Mar 2016

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Nevirapine (Primary) ; Antiretrovirals
  • Indications HIV infections; Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top